Replay available

Liquidia Corporation (LQDA) Q1 2026 Earnings Call

Liquidia Corporation (NASDAQ: LQDA) Q1 2026 earnings conference call, held 2026-05-11. Replay captured from the company's public earnings webcast.

Mon, May 11, 2026 at 8:30 AMendedReplay
Liquidia Corporation (LQDA) Q1 2026 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Jason Adair

Chief Business Officer

Dr. Robert Jeffs

Chief Executive Officer

Michael Cassetta

Chief Operating Officer & Chief Financial Officer

Amy Lee

Equity Research Analyst, Jefferies

Rusty Shundler

General Counsel

Brian Deschner

Equity Research Analyst, Raymond James

Scott Mumal

Chief Commercial Officer

Serge Bellinger

Equity Research Analyst, Needham & Company

Julian Harrison

Equity Research Analyst, BTIG

Dr. Rajiv Sagar

Chief Medical Officer

Ben Burnett

Equity Research Analyst, Wells Fargo Securities

Philip Eckert

Equity Research Analyst, LifeSci Capital

Replay transcript excerpt

Good morning and welcome to Liquidity Incorporation First Quarter 2026 Financial Results and Corporate Update Conference Call. My name is Jonathan and I will be your operator today. All participants are currently in a listen-only mode. Following the presentation, we will conduct a question and answer session. Instructions for joining the queue will be provided at that time. Please note that today's call is being recorded. And now I'd like to turn the call over to Jason Adair, the Quidius Chief Business Officer. You may proceed. Thank you and good morning, everyone. It's my pleasure to welcome you to our first quarter 2026 Financial Results and Corporate Update call. Joining me today are Dr. Robert Jeffs, Chief Executive Officer, Michael Cassetta, Chief Operating Officer and Chief Financial Officer, Dr. Rajiv Sagar, Chief Medical Officer, Scott Mumal, Chief Commercial Officer, and Rusty Shundler, our General Counsel. Before we begin, please note that today's discussion will include forward-looking statements, including statements regarding future results, product performance, and ongoing clinical or commercial activities. These statements are subject to risks and uncertainties that may cause actual results to differ materially. For further information, please refer to our filings with the SEC, which are available on our website. Please also note that our earnings release and our commentary include non-GAAP financial measures. Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures can be found in our earnings press release. With that, I'll turn the call over to Roger. Thanks, Jason, and good morning, everyone. We're delighted to share our business results with you today. We'll keep our prepared remarks somewhat brief this morning as w...

More from Liquidia Corporation